Skip to main content

Vertex (VRTX) - Get Vertex Pharmaceuticals Incorporated Report set plans Monday to sell 8 million newly issued shares.

The Cambridge, Mass., biotech said Merrill Lynch is sole book-runner, with Morgan Stanley as joint lead manager and UBS as co-manager.

Vertex, which has 111 million shares outstanding, fell 52 cents Monday to $34.82.

TheStreet Recommends